A Step Closer to Meeting the Threat of Avian Influenza
Author(s) -
Stacey SchultzCherry,
Jonathan A. McCullers
Publication year - 2006
Publication title -
plos medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.847
H-Index - 228
eISSN - 1549-1676
pISSN - 1549-1277
DOI - 10.1371/journal.pmed.0030375
Subject(s) - influenza a virus subtype h5n1 , virology , hemagglutinin (influenza) , biology , pandemic , attenuated vaccine , vaccination , virus , inactivated vaccine , adjuvant , influenza vaccine , immune system , immunology , medicine , infectious disease (medical specialty) , virulence , covid-19 , disease , genetics , gene , pathology
Schultz-Cherry discusses a new study that describes the generation of live, attenuated H5N1 influenza viruses that may be suitable candidates for use in humans.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom